For the 5th edition of the double-curricular dinners, we will have the honor to welcome Professor Françoise Galateau-Sallé, anatomopathologist and researcher - specialized in the study of mesothelioma - who will tell us in French about her background, her career and her work during this event.
>> REGISTRATION FORM <<
- To raise awareness of health research curricula among different audiences, in order to improve translational research
translational research and to facilitate the path of future students who want to get involved in these subjects.
- To sensitize participants to a multidisciplinary and holistic scientific approach.
- Bring together students interested in science and/or health in order to promote intellectual and scientific
intellectual and scientific emulation.
- To highlight the possibilities of a career path through the know-how of health professionals.
- To strengthen the links and the sharing of experience between students and professionals.
From 7:30 pm to 10 pm on Friday 31 March at the Institut Curie. 1 hour of presentation broadcast by videoconference, followed by 1.5 hours of discussion over an aperitif-dinner.
35 participants
Participation in the dinner is free and based on an online registration form.
Prof. Françoise Galateau-Sallé
Since 1980, Professor Galateau-Sallé has participated in the creation of Mesopath (malignant mesothelioma network) at the Biopathology Cancer Center Léon Bérard in Lyon, where she also works as an anatomo-pathologist. Mesopath is a network of experts spread all over France, at the origin of a standardized diagnostic validation procedure unique in the world allowing to refine considerably the diagnosis by standardizing the anatomopathological practices and the sampling procedures in the framework of pleural mesothelioma. Thus, she is developing a research activity in order to understand the mechanisms of cancerous transformation of the pleura and to identify biomarkers capable of recognizing precancerous states and of identifying unusual forms of mesothelioma among the included tumors. Professor Galateau-Sallé is also an editor at the Archives of Pathology & Laboratory Medicine, an editorial consultant to the European Society of Pathology and an expert at the National Cancer Institute.
Her research interests include mesothelial proliferation (benign and malignant), predictive biomarkers for mesothelioma, biobanking and artificial intelligence in pathology.
